MSB 5.50% $1.38 mesoblast limited

The All-Important Appendix 3C, page-6

  1. 7,281 Posts.
    lightbulb Created with Sketch. 45
    @musky45
    Essentially you are saying it will show cash received from royalties actually earned for September, October and November. madamswer's point, I believe, is it will still be 3 months of cash flow, regardless of the not uncommon time lag.

    I would hope there would be an increase in sales, but I still think the numbers will be small.

    More critically, I believe, JCR or Mesoblast should be able to provide some feedback on the effectiveness of the treatment so far. They now have 10 months of data to go on so, my question would be, is it working?
    Last edited by aatisket: 13/01/17
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.